School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, SUNY, Buffalo, New York, USA
School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, SUNY, Buffalo, New York, USA.
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.01367-17. Print 2017 Nov.
Acute kidney injury (AKI) occurs in a substantial proportion of critically ill patients receiving intravenous colistin. In the pharmacokinetic/toxicodynamic analysis reported here, the relationship of the occurrence of AKI to exposure to colistin and a number of potential patient factors was explored in 153 critically ill patients, none of whom were receiving renal replacement therapy. Tree-based modeling revealed that the rates of AKI were substantially higher when the average steady-state plasma colistin concentration was greater than ∼2 mg/liter.
急性肾损伤（AKI）在接受静脉注射黏菌素的危重症患者中占相当大的比例。在本报告的药代动力学/药效动力学分析中，在 153 例危重症患者中探讨了 AKI 的发生与黏菌素暴露以及许多潜在患者因素的关系，这些患者均未接受肾脏替代治疗。基于树的建模显示，当平均稳态血浆黏菌素浓度大于约 2mg/L 时，AKI 的发生率显著升高。
